Balanced Pharma
Reinventing medical and dental injections for a better patient experience
Analytics
Raised: $0
Aggregate Commitments $
Dalmore Group
04/11/2022
04/10/2023
$100
$25,000,000
$100
Equity - Common
RegA+
Seed
$4.00
$82,440,000
Rolling Commitments $
Active
05/21/2022
324
0%
0%
$0
Cornelius, North Carolina
Healthcare & Pharmaceuticals
Biotech
B2B
Medium
Low
Balance Sheet
|
Cash and Cash Equivalents |
$1,616,810 |
|
Investment Securities |
$0 |
|
Total Investments |
$0 |
|
Accounts and Notes Receivable |
$0 |
|
Loans |
$0 |
|
Property, Plant and Equipment (PP&E) |
$0 |
|
Property and Equipment |
$0 |
| Total Assets |
$1,696,346 |
|
Accounts Payable & Accrued Liabilities |
$3,558 |
|
Policy Liabilities and Accruals |
$0 |
|
Deposits |
$0 |
|
Long Term Debt |
$0 |
|
Total Liabilities |
$3,588 |
|
Total Stockholders' Equity |
$1,692,758 |
| Total Liabilities and Equity |
$1,696,346 |
Statement of Comprehensive Income Information
|
Total Revenues |
$0 |
|
Total Interest Income |
$0 |
|
Costs & Expenses Applicable to Rev |
$0 |
|
Total Interest Expenses |
$0 |
|
Depreciation and Amortization |
$0 |
| Net Income |
$-900,980 |
|
Earnings Per Share - Basic |
$0 |
|
Earnings Per Share - Diluted |
$0 |
Upgrade to gain access
-
$8.33 /month
billed annually - Free portfolio tracking. Limited reports and filters.
- Plan Includes:
- Everything in Free, plus
- Advanced company search ( limited filters)
- Founder profiles and exclusive webinars
- 2 Analyst Reports per month
- Get Starter Annual
Starter
-
$25 /month
billed annually - Unlimited analyst reports and market analytics.
- Plan Includes:
- Everything in Starter, plus
- Full access to all Analyst Reports
- Filter on Analyst Reports (e.g. Top Deal, Deal to Watch, etc.)
- Market Analytics
- Get Pro Annual
Pro
-
$41.67 /month
billed annually - Full site access including KingsCrowd ratings.
- Plan Includes:
- Everything in Pro, plus
- Search and filter companies by KingsCrowd ratings
- Company specific
KingsCrowd rating and risk assessment
- Get Merlin Annual